Brief: Genenta Science Announces Receipt Of Nasdaq Minimum Bid Price Deficiency Notification
21/10/2026 23:10
BRIEF-Genenta Science Announces Receipt Of Nasdaq Minimum Bid Price Deficiency Notification Oct 21 (Reuters) - Genenta Science SPA K5Fy.F:
GENENTA SCIENCE ANNOUNCES RECEIPT OF NASDAQ MINIMUM BID PRICE DEFICIENCY NOTIFICATION
Source text: ID:nGNX5Sv8x0
Further company coverage: [K5Fy.F]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genenta Science SpA
See all newsBrief: Genenta Science SPA Milan Tribunal Issues Interim Order Suspending Board Appointment Resolution From June 29 Shareholders' Meeting - SEC Filing
Brief: Genenta Science Announces Receipt Of Nasdaq Minimum Bid Price Deficiency Notification
Brief: Genenta Science Court Of Milan Denies Interim Suspension Of Atc Capital Increase
Brief: Genenta & Anemocyte Announce Strategic Partnership To Advance Off-The-Shelf LVV Plasmid Dna Production
Brief: Genenta Science SpA -Entered Amendment To ATM Sales Agreement Dated April 26